Finerenone for reducing protein in urine in type 2 diabetes with kidney disease
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a medication called finerenone to see if it can lower the amount of protein in your urine, which is a sign of kidney damage. It is for people with type 2 diabetes and chronic kidney disease who are already on standard blood pressure medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes.
- Your kidney function is at a certain level (eGFR of 30 or higher) and you have protein in your urine (UACR between 30 and 2000).
- You are already taking an ACE inhibitor or ARB (blood pressure medications) at the highest dose you can tolerate for at least 3 months.
- Your blood potassium level is not too high (5.0 or lower).
- You have not had recent heart problems, stroke, or heart failure hospitalization in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding finerenone to your current diabetes medications can better protect your heart and kidneys. It is for people with type 2 diabetes who already take an SGLT2 inhibitor and an ACE inhibitor or ARB.
This study compares two experimental treatments—one that reduces protein in urine and another that may help control blood sugar and weight—for people with chronic kidney disease. It aims to find safer, more effective ways to slow kidney damage.
This trial tests if a medicine called finerenone can protect kidney function in people with type 2 diabetes and early-to-moderate chronic kidney disease. It may be an option if you are already on blood pressure medication and have some protein in your urine.
This trial studies whether a drug called finerenone can safely and effectively treat kidney disease caused by type 2 diabetes. If you qualify, you would take finerenone while your regular diabetes and blood pressure medications continue unchanged.
This study looks at how well finerenone, a medicine for kidney disease, works in everyday care for people with type 2 diabetes and chronic kidney disease. It aims to see how the medicine helps manage your condition over time.
This trial tests if finerenone can protect kidneys in people with chronic kidney disease who are not taking common blood pressure medications called ACE inhibitors, ARBs, or renin inhibitors. It may help slow kidney damage.
Hear when a new Albuminuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.